Wagner, Michael J.
Lyons, Yasmin A.
Siedel, Jean H.
Dood, Robert
Nagaraja, Archana S.
Haemmerle, Monika
Mangala, Lingegowda S.
Chanana, Pritha
Lazar, Alexander J.
Wang, Wei-Lien
Ravi, Vinod
Holland, Eric C.
Sood, Anil K.
Funding for this research was provided by:
NCI-DHHS-NIH T32 Training Grant (T32CA009666)
QuadW-AACR Fellowship for Clinical/Translational Sarcoma Research
NCI (P30 CA015704, P50 CA217685, P30 CA16672)
Conquer Cancer of ASCO Young Investigator Award
Frank McGraw Memorial Chair in Cancer Research
American Cancer Society Research Professor Award
Article History
Received: 6 February 2021
Accepted: 15 April 2021
First Online: 30 April 2021
Competing interests
: M.W.: advisory fees (Adaptimmune, Tempus, Deciphera); research funding to institution (Adaptimmune, Deciphera, GSK, Athenex, Incyte). A.K.S.: consulting (Merck, Kiyatec); shareholder (BioPath); research funding (M-Trap). Y.A.L., J.H.S., R.D., A.S.N., M.H., L.S.M., P.C., A.J.L., W.L.W., V.R. had no competing interests to declare.